DescriptionIndicationsContraIndicationsDosageWarning/Precautions

TICLOP TABLETS

DESCRIPTION

Introduction

TICLOPIDINE

XX reduces platelet aggregation. XX acts by producing changes (may be irreversible) to the platelet membrane reducing their ability to form blood clots with fibrin. itused in combination with other antiplatelet drugs to reduce the risk of further thrombolytic events. itperticularly useful in patients who cannot tolerate aspirin.

Category:

  • Drugs affecting the blood
  • Anticoagulants/Platelet deaggregators

Primary Characterstics

belongs to Pyridine. . The Molecular Weight of Ticlopidine is 300.20.

Pharmacokinetics

Plasma protien binding is 98 %. Renal Excretion accounts for 60 % and plasma half life is 12.6 hr.